-
公开(公告)号:US20230079819A1
公开(公告)日:2023-03-16
申请号:US17425140
申请日:2020-01-29
Applicant: Foghorn Therapeutics Inc.
Inventor: Rishi G. VASWANI , Neville John ANTHONY , David Simon MILLAN , Shawn E.R. SCHILLER , Kevin J. WILSON , David S. HUANG
IPC: C07D417/14 , A61P35/00 , C07D498/04 , C07D417/12 , C07D487/04 , C07D491/08 , C07D471/04 , C07D491/107 , C07D491/048
Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
-
公开(公告)号:US20230121497A1
公开(公告)日:2023-04-20
申请号:US17795929
申请日:2021-01-29
Applicant: Foghorn Therapeutics Inc.
Inventor: Rishi G. VASWANI , David S. HUANG , Kevin J. WILSON , Shawn E.R. SCHILLER , Neville John ANTHONY
IPC: C07D471/04 , C07D403/14 , C07D401/14 , C07D413/14 , C07D403/12 , C07D405/14 , C07D417/14
Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
-
公开(公告)号:US20210038611A1
公开(公告)日:2021-02-11
申请号:US16965822
申请日:2019-01-29
Applicant: Foghorn Therapeutics Inc.
Inventor: Neville John ANTHONY , David Simon MILLAN , Rishi G. VASWANI , Shawn E.R. SCHILLER
IPC: A61K31/541 , A61K31/4409 , C07D417/14 , A61P35/04 , C07D277/46 , C07D417/10 , C07D417/04 , A61K31/4439 , A61K31/427 , A61K31/4709 , A61K31/4425 , A61K31/5377 , A61K31/506 , A61K31/496 , A61K45/06
Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
-
公开(公告)号:US20240158387A1
公开(公告)日:2024-05-16
申请号:US18281022
申请日:2022-03-09
Applicant: FOGHORN THERAPEUTICS INC.
Inventor: Rishi G. VASWANI , Chong-Hui GU
IPC: C07D417/14 , A61K9/48 , A61K45/06
CPC classification number: C07D417/14 , A61K9/4816 , A61K9/4858 , A61K9/4866 , A61K45/06 , C07B2200/13
Abstract: Disclosed are crystalline forms of the compound of formula (I): (I) Also disclosed are compositions containing the crystalline forms of the compound of formula (I) and methods of their use. The methods may be for treating cancer in a subject in need thereof, e.g., by administering to the subject an effective amount of the crystalline form disclosed herein or its composition.
-
公开(公告)号:US20220119378A1
公开(公告)日:2022-04-21
申请号:US17425041
申请日:2020-01-29
Applicant: Foghorn Therapeutics Inc.
Inventor: Neville John ANTHONY , Rishi G. VASWANI , David Simon MILLAN , Shawn E.R. SCHILLER
IPC: C07D417/14 , A61P35/00 , C07D471/04
Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
-
公开(公告)号:US20240101550A1
公开(公告)日:2024-03-28
申请号:US18373518
申请日:2023-09-27
Applicant: FOGHORN THERAPEUTICS INC.
Inventor: Rishi G. VASWANI , David S. HUANG
IPC: C07D417/14 , A61P35/00 , A61P35/02
CPC classification number: C07D417/14 , A61P35/00 , A61P35/02
Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
-
公开(公告)号:US20230416248A1
公开(公告)日:2023-12-28
申请号:US18252228
申请日:2021-11-10
Applicant: Foghorn Therapeutics Inc.
Inventor: Kevin J. WILSON , Solymar NEGRETTI , Shawn E.R. SCHILLER , Rishi G. VASWANI , David S. HUANG , Johannes H. VOIGT
IPC: C07D471/04 , C07D519/00 , A61P35/00
CPC classification number: C07D471/04 , C07D519/00 , A61P35/00
Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
-
公开(公告)号:US20230129003A1
公开(公告)日:2023-04-27
申请号:US17963576
申请日:2022-10-11
Applicant: Foghorn Therapeutics Inc.
Inventor: Rishi G. VASWANI , David S. HUANG
IPC: C07D417/14 , A61P35/02 , A61P35/00
Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
-
公开(公告)号:US20230149414A1
公开(公告)日:2023-05-18
申请号:US17795747
申请日:2021-01-29
Applicant: Foghorn Therapeutics Inc.
Inventor: Neville John ANTHONY , Rishi G. VASWANI , David Simon MILLAN , Shawn E.R. SCHILLER , Kevin J. WILSON
IPC: A61K31/5377 , A61K45/06 , C07D277/46 , A61K31/427 , A61K31/4439 , C07D417/10 , A61K31/506 , C07D417/14 , A61K31/444 , A61P35/00
CPC classification number: A61K31/5377 , A61K45/06 , C07D277/46 , A61K31/427 , A61K31/4439 , C07D417/10 , A61K31/506 , C07D417/14 , A61K31/444 , A61P35/00
Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
-
公开(公告)号:US20230138480A1
公开(公告)日:2023-05-04
申请号:US17965145
申请日:2022-10-13
Applicant: Foghorn Therapeutics Inc.
Inventor: Neville John ANTHONY , David Simon MILLAN , Rishi G. VASWANI , Shawn E.R. SCHILLER
IPC: A61K31/541 , A61P35/04 , A61K31/427 , A61K31/4409 , A61K31/4425 , A61K31/4439 , A61K31/4709 , A61K31/496 , A61K31/506 , A61K31/5377 , A61K45/06 , C07D277/46 , C07D417/04 , C07D417/10 , C07D417/14
Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
-
-
-
-
-
-
-
-
-